Radical Numerics launched with a $50 million seed round led by Emergence Capital as the AI biotech pushes multimodal models trained across DNA, RNA, and proteins. The company said its integrated platform—designed to reason across multiple dimensions of biology—targets applications in cancer diagnostics, drug target identification, and biosecurity. Founders include Eric Nguyen and Michael Poli, creators of the Evo generative genomics model series. Radical Numerics also said it is previewing its next-generation genomic language model, Omnii, and is partnering with an undisclosed cancer diagnostics company to apply the approach to pancreatic and multi-cancer detection.